Simplify Asset Management Inc. Dexcom Inc Transaction History

Simplify Asset Management Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$75.49 - $124.16 $390,811 - $642,776	5,177 Added 223.05%	7,498 $930,000
Q3 2023 Nov 14, 2023	SELL	$86.06 - $137.93 $1.27 Million - $2.03 Million	-14,742 Reduced 86.4%	2,321 $216,000
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $851,960 - $992,173	7,575 Added 79.84%	17,063 $2.19 Million
Q1 2023 May 10, 2023	SELL	$104.0 - $122.92 $1.26 Million - $1.49 Million	-12,086 Reduced 56.02%	9,488 $1.1 Million
Q4 2022 Feb 10, 2023	BUY	$84.98 - $122.67 $1.45 Million - $2.09 Million	17,010 Added 372.7%	21,574 $2.44 Million
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $108,798 - $134,206	1,425 Added 45.4%	4,564 $368,000
Q2 2022 Aug 11, 2022	BUY	$67.99 - $132.89 $132,580 - $259,135	1,950 Added 164.0%	3,139 $234,000
Q1 2022 May 13, 2022	SELL	$94.08 - $130.2 $2,069 - $2,864	-22 Reduced 1.82%	1,189 $608,000
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $157,272 - $197,175	1,211 New	1,211 $650,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Simplify Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Simplify Asset Management Inc. with notifications on news.